{"id":4071,"date":"2019-02-11T16:11:13","date_gmt":"2019-02-11T10:41:13","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=4071"},"modified":"2025-05-07T12:14:56","modified_gmt":"2025-05-07T06:44:56","slug":"raynauds-disease-a-debilitating-condition","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition","title":{"rendered":"Raynaud’s Disease -A debilitating condition"},"content":{"rendered":"\n

Raynaud’s Disease<\/strong> (RD), also called Raynaud’s phenomenon<\/strong>, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold or feeling stressed in some areas of the body like fingers and toes, blood can’t reach to the epidermis (surface of the skin) and the affected areas turn white and blue. When the blood flow returns, the skin turns red. The disease can also affect other areas of the body like nose, lips, ears and even nipples. People who have been affected by Raynaud’s disease<\/a> is approximately 28 million<\/strong> people in the US. <\/p>\n\n\n\n

Community-based surveys have been done to estimate the prevalence of Raynaud’s<\/a> phenomenon (RP)<\/strong> in the general population. The estimates of the prevalence of RP have ranged from 3 to 20 percent in women<\/strong> and 3 to 14 percent in men<\/strong> in these surveys.<\/p>\n\n\n\n

Raynaud <\/a>phenomena occur more frequently in women (about 20% to 30%<\/strong>), particularly in younger age populations (teens to 20s<\/strong>). The female to male ratio is 9 to 1<\/strong>.<\/p>\n\n\n\n

There are two types: – Primary Raynaud’s and secondary Raynaud’s<\/strong>.<\/p>\n\n\n\n

Primary Raynaud’s occurs on its own. In UK<\/strong>, approximately 10 million<\/strong> people are affected by the disease and can be difficult to treat. The pathophysiology of primary Raynaud’s phenomenon remains uncertain. Other is secondary Raynaud’s, which is caused by injuries, other diseases, or certain medicines. One in 10 people who have Primary Raynaud’s will go on to develop secondary Raynaud’s. <\/p>\n\n\n\n

The market of Raynaud’s <\/a>phenomenon is largely based on drugs and some key players in the global market of Raynaud’s phenomenon that are- Covis Pharmaceuticals Inc, Allergan Plc, Apricus Biosciences Inc, Sanofi-Aventis, Inc., GlaxoSmithKline, TEVA Pharmaceuticals Industries Ltd., Mylan Inc., Sandoz International GmbH, and Unichempharma<\/strong> etc.<\/p>\n\n\n\n

Albeit causes of the\ndisease is unknown, but it seems that blood vessels in the hands and feet\nappear to overreact to cold temperatures or stress. When exposed to cold\ntemperature like putting the hands, taking shower in cold water etc. is the\nmost likely to affect. Sometimes, emotional stress can also trigger in some\npeople. It can be treated with\nsurgical treatment in severe conditions like serious tissue damage, and skin\nulcers.<\/p>\n","protected":false},"excerpt":{"rendered":"

Raynaud’s Disease (RD), also called Raynaud’s phenomenon, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold or feeling stressed in some areas of the body like fingers and toes, blood can’t reach to the epidermis (surface of the skin) and the affected areas turn white and blue. When the blood flow […]<\/p>\n","protected":false},"author":1,"featured_media":4072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[2541,2543,2542,985,317,2547,2551,2552,2546,2544,2545,2548],"industry":[17225],"therapeutic_areas":[17236],"class_list":["post-4071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-allergan-plc","tag-apricus-biosciences-inc","tag-covis-pharmaceuticals-inc","tag-glaxosmithkline","tag-inc","tag-mylan-inc","tag-raynauds-disease-rd","tag-raynauds-phenomenon","tag-sandoz-international-gmbh","tag-sanofi-aventis","tag-teva-pharmaceuticals-industries-ltd","tag-unichempharma","industry-pharmaceutical","therapeutic_areas-otolaryngology"],"acf":[],"yoast_head":"\nRaynaud's Disease -A debilitating condition - DelveInsight<\/title>\n<meta name=\"description\" content=\"Raynaud's Disease (RD), also called Raynaud's phenomenon, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Raynaud's Disease -A debilitating condition - DelveInsight\" \/>\n<meta property=\"og:description\" content=\"Raynaud's Disease (RD), also called Raynaud's phenomenon, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-11T10:41:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-07T06:44:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/14013646\/raynaud.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"720\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Raynaud's Disease -A debilitating condition - DelveInsight","description":"Raynaud's Disease (RD), also called Raynaud's phenomenon, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition","og_locale":"en_US","og_type":"article","og_title":"Raynaud's Disease -A debilitating condition - DelveInsight","og_description":"Raynaud's Disease (RD), also called Raynaud's phenomenon, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold...","og_url":"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2019-02-11T10:41:13+00:00","article_modified_time":"2025-05-07T06:44:56+00:00","og_image":[{"width":720,"height":400,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/14013646\/raynaud.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition","url":"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition","name":"Raynaud's Disease -A debilitating condition - DelveInsight","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/14013646\/raynaud.jpg","datePublished":"2019-02-11T10:41:13+00:00","dateModified":"2025-05-07T06:44:56+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Raynaud's Disease (RD), also called Raynaud's phenomenon, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/raynauds-disease-a-debilitating-condition#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/14013646\/raynaud.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/14013646\/raynaud.jpg","width":720,"height":400,"caption":"Raynaud's disease"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/14013646\/raynaud-300x167.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Allergan Plc<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Apricus Biosciences Inc<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Covis Pharmaceuticals Inc<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">GlaxoSmithKline<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Inc.<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Mylan Inc.<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Raynaud's Disease (RD)<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Raynaud's phenomenon<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Sandoz International GmbH<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Sanofi-Aventis<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">TEVA Pharmaceuticals Industries Ltd.<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Unichempharma<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Allergan Plc<\/span>","<span class=\"advgb-post-tax-term\">Apricus Biosciences Inc<\/span>","<span class=\"advgb-post-tax-term\">Covis Pharmaceuticals Inc<\/span>","<span class=\"advgb-post-tax-term\">GlaxoSmithKline<\/span>","<span class=\"advgb-post-tax-term\">Inc.<\/span>","<span class=\"advgb-post-tax-term\">Mylan Inc.<\/span>","<span class=\"advgb-post-tax-term\">Raynaud's Disease (RD)<\/span>","<span class=\"advgb-post-tax-term\">Raynaud's phenomenon<\/span>","<span class=\"advgb-post-tax-term\">Sandoz International GmbH<\/span>","<span class=\"advgb-post-tax-term\">Sanofi-Aventis<\/span>","<span class=\"advgb-post-tax-term\">TEVA Pharmaceuticals Industries Ltd.<\/span>","<span class=\"advgb-post-tax-term\">Unichempharma<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 7 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Feb 11, 2019","modified":"Updated on May 7, 2025"},"absolute_dates_time":{"created":"Posted on Feb 11, 2019 4:11 pm","modified":"Updated on May 7, 2025 12:14 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=4071"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4071\/revisions"}],"predecessor-version":[{"id":31821,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4071\/revisions\/31821"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/4072"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=4071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=4071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=4071"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=4071"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=4071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}